Convergence Pharmaceuticals Holdings, Evotec deal

Evotec and Convergence's Panion Ltd. subsidiary partnered to develop analgesics to treat chronic pain. Panion received a £2.4 million ($4 million) Biomedical Catalyst early stage grant from the U.K. T...